Literature DB >> 9296487

Has BCG attenuated to impotence?

M A Behr, P M Small.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9296487     DOI： 10.1038/38151

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  40 in total

1.  PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family.

Authors:  Limei Meng Okkels; Inger Brock; Frank Follmann; Else Marie Agger; Sandra M Arend; Tom H M Ottenhoff; Fredrik Oftung; Ida Rosenkrands; Peter Andersen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

Authors:  Vasan K Sambandamurthy; Steven C Derrick; Kripa V Jalapathy; Bing Chen; Robert G Russell; Sheldon L Morris; William R Jacobs
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Strain-dependent variation in Mycobacterium bovis BCG-induced human T-cell activation and gamma interferon production in vitro.

Authors:  Ana M Aguirre-Blanco; Pauline T Lukey; Jacqueline M Cliff; Hazel M Dockrell
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

4.  Genomic Changes Associated with the Loss of Nocardia brasiliensis Virulence in Mice after 200 In Vitro Passages.

Authors:  Carolina Gonzalez-Carrillo; Cassandra Millan-Sauceda; Hector Gerardo Lozano-Garza; Rocio Ortiz-Lopez; Ramiro Elizondo-Gonzalez; Oliverio Welsh; Jorge Ocampo-Candiani; Lucio Vera-Cabrera
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

5.  Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

Authors:  Pål Johansen; Antonia Fettelschoss; Beat Amstutz; Petra Selchow; Ying Waeckerle-Men; Peter Keller; Vojo Deretic; Leonhard Held; Thomas M Kündig; Erik C Böttger; Peter Sander
Journal:  Clin Vaccine Immunol       Date:  2011-04-06

Review 6.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

7.  The tuberculosis epidemic. Scientific challenges and opportunities.

Authors:  A M Ginsberg
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

8.  Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.

Authors:  L Holten-Andersen; T M Doherty; K S Korsholm; P Andersen
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

9.  A comprehensive survey of single nucleotide polymorphisms (SNPs) across Mycobacterium bovis strains and M. bovis BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis strains and M. bovis BCG strains.

Authors:  M Carmen Garcia Pelayo; Swapna Uplekar; Andrew Keniry; Pablo Mendoza Lopez; Thierry Garnier; Javier Nunez Garcia; Laura Boschiroli; Xiangmei Zhou; Julian Parkhill; Noel Smith; R Glyn Hewinson; Stewart T Cole; Stephen V Gordon
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

10.  Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Authors:  Adam Belley; David Alexander; Tania Di Pietrantonio; Manon Girard; Joses Jones; Erwin Schurr; Jun Liu; David R Sherman; Marcel A Behr
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.